Tatsuro Furui

Gifu-shi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

CT- and MR Imaging-based Radiomics Approach to Differentiating Ovarian Mature and Immature Teratomas: Can MR Imaging-based Radiomics Predict the Histological Grade of Immature Teratomas?

CT- and MR Imaging-based Radiomics Approach to Differentiating Ovarian Mature and Immature Teratomas: Can MR Imaging-based Radiomics Predict the Histological Grade of Immature Teratomas?

Journal: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine

Published: June 17, 2026

Proteomic profiling identifies circulating soluble MCAM/CD146 as a candidate biomarker for abnormal semen parameters in male infertility.

Proteomic profiling identifies circulating soluble MCAM/CD146 as a candidate biomarker for abnormal semen parameters in male infertility.

Journal: Annals of clinical biochemistry

Published: May 12, 2026

MRI features of ovarian metastases from appendiceal tumors and primary ovarian mucinous carcinoma: a comparative study.

MRI features of ovarian metastases from appendiceal tumors and primary ovarian mucinous carcinoma: a comparative study.

Journal: Japanese journal of radiology

Published: February 19, 2026

Current Status of Oncofertility in Young Patients with Breast Cancer

Current Status of Oncofertility in Young Patients with Breast Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

Journal: Advances in therapy

Published: December 24, 2025

Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.

Journal: Advances in therapy

Published: August 29, 2025

Effectiveness of T2-weighted and contrast-enhanced T1-weighted multivane sequences in the preoperative evaluation of uterine endometrial cancer.

Effectiveness of T2-weighted and contrast-enhanced T1-weighted multivane sequences in the preoperative evaluation of uterine endometrial cancer.

Journal: Abdominal radiology (New York)

Published: May 14, 2025

Differences in infant feeding methods at one month postpartum among women with psychiatric disorders and factors influencing exclusive breastfeeding.

Differences in infant feeding methods at one month postpartum among women with psychiatric disorders and factors influencing exclusive breastfeeding.

Journal: Child and adolescent psychiatry and mental health

Published: March 31, 2025

Successful Treatment of Unscheduled Uterine Bleeding During Transdermal Menopausal Hormone Therapy Combined With Bazedoxifene.

Successful Treatment of Unscheduled Uterine Bleeding During Transdermal Menopausal Hormone Therapy Combined With Bazedoxifene.

Journal: Cureus

Published: March 31, 2025

Prediction of grading of ovarian endometrioid carcinoma using conventional MRI features.

Prediction of grading of ovarian endometrioid carcinoma using conventional MRI features.

Journal: Japanese journal of radiology

Published: October 21, 2024

Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial.

Evaluating the Efficacy and Safety of 48-Week Low-Dose Dienogest Administration in Patients With Dysmenorrhea Caused by Endometriosis: Protocol for a Randomized, Open-Label, Parallel-Group Trial.

Journal: JMIR research protocols

Published: September 14, 2024

Correction: A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.

Correction: A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.

Journal: European radiology

Published: September 02, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026